1. Introduction {#sec0001}
===============

For over a hundred years psychotic disorders have been separated into two main varieties, schizophrenia and manic-depressive psychosis. This distinction has proved highly useful clinically and has been of heuristic value. Recent neurobiological literature supports that schizophrenia and bipolar disorder share genetic ([@bib0050]; [@bib0032]; [@bib0009]) and neurocognitive characteristics ([@bib0029]), supporting that the two disorders are related at the aetiological level.

An important line of research that may help to clarify the common and different neurophysiological underpinnings of both disorders is brain morphology. A number of brain studies using structural magnetic resonance imaging (sMRI) have been carried out ([@bib0004]; [@bib0001]). Among these, those based on voxel-based morphometry (VBM) and surface-based morphometry (SBM) are relevant as they allow characterizing the focal changes in grey matter (GM) tissue. In contrast to VBM, which identifies regional differences in GM volume, SBM allows measuring additional local features of the cortex, including cortical thickness (CT), cortical surface area (SA), gyrification index (GI), and cortical volume (CV), the later which is a product of CT and SA of every cortical region. Notably, recent studies have found that CT and SA seem to be heritable but genetically and phenotypically independent ([@bib0045]; [@bib0064]), and they result from different ontogenic stages during corticogenesis ([@bib0049]). In fact, it has been suggested that independent processes regulate CT and SA ([@bib0045]; [@bib0052]): while CT may be more influenced by environmental and neurodegenerative factors ([@bib0003]), cortical SA developmental trajectories may be predominantly influenced by early neurodevelopmental and genetic factors ([@bib0045]; [@bib0064]). Thus, investigating SA and CT differences separately might lead to the identification of more specific imaging biomarkers that may provide greater insight into the neurobiology of psychiatric disorders.

Various studies have reported cortical thinning in schizophrenia compared to healthy subjects, especially in frontal and temporal regions ([@bib0052]; [@bib0059]; [@bib0018]; [@bib0040]; [@bib0041]), however the evidence in bipolar disorder is less conclusive ([@bib0021]; [@bib0012]; [@bib0015]; [@bib0016]; [@bib0033]; [@bib0035]). Recently, two meta-analyses by the Enhancing Neuro Imaging Genetics Through Meta-analyses (ENIGMA) Consortium have conducted the largest studies of CT and SA in both schizophrenia and bipolar disorder. The ENIGMA Schizophrenia Working Group compared 4474 patients with schizophrenia to 5098 healthy subjects and found widespread cortical thinning, with the largest effect sizes in frontal and temporal regions, as well as widespread smaller cortical SA without regional specificity ([@bib0060]). On the other hand, the ENIGMA Bipolar Disorder Working Group involved 2447 bipolar patients and 4056 healthy controls. Cortical gray matter was thinner in frontal, temporal and parietal regions of both brain hemispheres, and cortical SA was reduced in isolated brain regions associated with a history of psychosis ([@bib0022]). Still, no meta-analysis studies based on CT and SA have been conducted comparing patients with schizophrenia and bipolar disorder.

Cortical gyrification**,** represented by the local gyrification index (GI), is a morphological measure that captures a developmental window different from CT and SA. It measures the amount of cortex buried within the sulcal folds as compared with the amount of visible cortex in circular regions of interest ([@bib0055]). Cortical gyrification is of great interest because is thought to be determined by factors that occur early in the maturation of the brain. Thus, alterations in GI could reflect trait vulnerability to mental disorders ([@bib0051]).

Gyrification studies in schizophrenia have alternately reported both decreased and increased GI, as reviewed by [@bib0062]). However, decreased GI has been the more replicated finding in recent studies ([@bib0041]; [@bib0042]; [@bib0036]; [@bib0044]; [@bib0043]). Abnormal cortical gyrification has been described in patients with a first episode of psychosis, siblings of patients, as well as high-risk and at-risk individuals, suggesting it can be an imaging biomarker for psychosis ([@bib0036]; [@bib0061]). Likewise, reduced GI in patients with bipolar disorder has been found in a few studies, along with progressive changes of brain gyrification in different stages of the disorder ([@bib0007]; [@bib0046]). As in previous studies using different brain imaging techniques, studies directly comparing gyrification patterns between schizophrenia and bipolar disorder are scarce and included small samples sizes. Decreased GI has been demonstrated in both disorders compared to healthy subjects, but it seems to be more pronounced in schizophrenia ([@bib0043]; [@bib0037]). By contrast, higher GI has also been described in both disorders, with psychotic bipolar patients showing higher GI in cingulate cortex compared to schizophrenia and healthy subjects ([@bib0040]). Thus, further studies providing additional data are required.

The more comprehensive SBM analysis to date, in terms of CT, CV, and SA, was reported by [@bib0052]). They analyzed 173 patients with schizophrenia, 139 patients with bipolar disorder and 207 healthy subjects. Patients with schizophrenia showed widespread CV reduction driven by both CT and SA reductions, compared to healthy subjects. By contrast, bipolar patients only showed CT reductions in frontal, parietal and temporal regions, but there were no significant differences in CV or SA in comparison to healthy subjects. However, this finding still needs to be replicated by taking into account the total brain volume as a confounding factor in the analysis, because unlike CT, SA and CV are highly correlated with total brain volume ([@bib0064]).

The profiles of cortical abnormalities in schizophrenia and bipolar disorder, and how far they resemble each other, have only been studied to a limited extent. The aim of this study is to investigate and compare the brain cortical alterations that underlie schizophrenia and bipolar disorder. To circumvent the limitations of previous studies related to examining a single or a few brain features and the lack of explicit inter-group comparisons between patients with both pathologies, in this work three groups of subjects are studied using multiple SBM features. Specifically, 128 patients with schizophrenia, 128 patients with bipolar disorder, and 127 healthy subjects are compared based on four local cortical measures: (1) cortical volume, (2) cortical thickness, (3) surface area, and (4) gyrification index. Given that the brain abnormalities occurring in these two disorders may affect multiple and distinct brain morphological features, the analysis of different metrics may be more specific and sensitive in discriminating the similarities and differences between disorders. We hypothesize that if schizophrenia and bipolar disorder share a common underlying pathophysiology, then these similarities must be also reflected on their brain structural changes.

2. Method {#sec0002}
=========

2.1. Participants {#sec0003}
-----------------

The patient sample (*n* = 256) consisted of 128 patients with schizophrenia and 128 patients with bipolar disorder recruited from two hospitals (Hospital Benito Menni, Sant Boi de Llobregat; and Hospital Clínic in Barcelona). All patients were diagnosed using DSM-IV criteria. Patients were excluded if: (a) they were aged \<18 years or \>65 years, (b) had a history of brain trauma or neurological disease, and (c) had shown alcohol/substance abuse within 12 months prior to participation. Clinical evaluation also included the Positive and Negative Syndrome Scale (PANSS) ([@bib0028]), and in the bipolar disorder group symptoms were also scored using the Young Mania Rating Scale (YMRS) ([@bib0065]) and Hamilton Depression Rating Scale HDRS-21 ([@bib0020]) and the Montgomery-Åsberg Depression Rating Scale (MADRS) ([@bib0038]). Overall severity of illness was rated using the Global Assessment of Functioning scale (GAF) ([@bib0013]). Pre-morbid IQ was estimated using the Word Accentuation Test (Test de Acentuación de Palabras, TAP; ([@bib0011], [@bib0019]), a word reading test requiring pronunciation of Spanish words whose accents have been removed. This test is conceptually similar to the UK National Adult Reading Test ([@bib0039]) and the American Wide-Range Achievement Test ([@bib0063]). Patients were also required to have a current IQ in the normal range (i.e.,\>70), as measured using four subtests of the Wechsler Adult Intelligence Scale III (WAIS-III: vocabulary, similarities, block design, and matrix reasoning).

Patients with schizophrenia were on treatment with antipsychotics (second generation AP *n* = 81, first generation AP *n* = 9; combination *n* = 31) with a chlorpromazine equivalent doses of 585 mg/d (SD± 449) (Data missing *n* = 7). Most of the bipolar patients were on treatment with mood stabilizers (*n* = 100) (lithium alone or in combination *n* = 78, valproate alone or in combination *n* = 14, other mood stabilizers *n* = 8) and with antidepressants (*n* = 30) (Data missing for *n* = 13); of them 81 were taking antipsychotics (second generation AP *n* = 67, first generation AP *n* = 7; combination *n* = 7) with a chlorpromazine equivalent doses of 308 mg/d (SD ± 263) (Data missing for *n* = 10).

A subsample of the subjects included in this study was previously included in another study by our group. Specifically, 37 patients with schizophrenia, 38 patients with bipolar disorder, and 38 healthy controls were analyzed using VBM 6.

The control sample consisted of 127 healthy individuals selected to be age-, sex- and estimated premorbid IQ-matched to the patients and met the same exclusion criteria. All controls were recruited from non-medical staff working in the hospital, their relatives and acquaintances, plus independent sources in the community. They were questioned and excluded if they reported a history of mental illness and/or treatment with psychotropic medication. All individuals were right-handed.

All participants gave written informed consent and the study was approved by the hospital research ethics committee.

2.2. MRI data acquisition {#sec0004}
-------------------------

All subjects were scanned in the same 1.5 Tesla GE Signa scanner (General Electric Medical Systems, Milwaukee, WI, USA) located at the Sant Joan de Déu Hospital in Barcelona (Spain). High-resolution structural-T1 MRI data were acquired with the following acquisition parameters: matrix size 512 × 512; 180 contiguous axial slices; voxel resolution 0.47 ×0.47 × 1 mm^3^; echo (TE), repetition (TR) and inversion (TI) times (TE/TR/TI) = 3.93 ms/2000 ms/710 ms, respectively; flip angle 15°.

2.3. Surface-based morphometry {#sec0005}
------------------------------

Structural MRI data were analyzed with the FreeSurfer image analysis suite, (<http://surfer.nmr.mgh.harvard.edu/>). Briefly, the pre-processing included motion correction, removal of non-brain tissue, automated Talairach transformation, tessellation of the grey- and white-matter boundaries and surface deformation ([@bib0014]). A number of deformation procedures were performed in the data analysis pipeline, including surface inflation and registration to a spherical atlas. This method uses both intensity and continuity information from the entire three-dimensional images in the segmentation and deformation procedures to produce vertex-wise representations of CT, SA, CV, and GI. The resultant maps are sensitive to sub-millimeter differences between groups and have been validated against histological data ([@bib0053]).

All subjects included in this study passed the standardized quality-control protocols from the ENIGMA consortium (<http://enigma.ini.usc.edu/protocols/imaging-protocols>) that have previously been applied in large-scale multi-centre studies of major depression and bipolar disorder (add ref: <https://www.nature.com/articles/mp201773>).

Prior to the statistical analyses, the individual CT, SA, CV, and GI maps were smoothed using a 2D Gaussian filter on the cortex with a full width at half maximum of 20 mm ([@bib0008]). Finally, general linear models were applied to the individual maps and the intracranial volume was included as a covariate in the models ([@bib0042]). As all groups are matched by age and gender, these factors were not included in the statistical model. However, we repeated the analyses and verified that the results did not change after controlling for these factors. Statistical inference was carried out with FreeSurfer tools based on non-parametric permutation testing, using a cluster-wise correction method for multiple comparisons with initial cluster-forming threshold of sig = 2.6 (i.e., *p* \< 0.0025, two tails) and 5000 iterations applied. In these analyses, only those clusters with a corrected value of *p* \< 0.05 were considered significant. Anatomical locations of the significant regions were determined with reference to the surface atlas included in FreeSurfer.

3. Results {#sec0006}
==========

Demographic, clinical and neuropsychological data for the patients and controls are shown in [Table 1](#tbl0001){ref-type="table"}. Differences in demographic characteristics among the groups were examined using chi-square tests for categorical variables and ANOVA tests for continuous variables. The groups were matched for age, sex and estimated premorbid IQ (TAP score).Table 1Demographic and clinical features of the patients and controlsTable 1Patients with schizophrenia (*N* = 128)Patients with bipolar disorder (*N* = 128)Controls (*N* = 127)P valueAge (years)41 ± 1041 ± 1039 ± 100.334Sex (male/female)74/5474/5473/540.998Pre-morbid IQ (TAP)22 ± 4 (a)22 ± 4 (b)22 ± 4 (i)0.288Age of onset (years)22 ± 6 (b)26 ± 9 (e)Duration of illness (years)18 ± 11 (b)14 ± 10 (e)Positive syndrome13 ± 5 (c)7 ± 4 (f)Negative syndrome17 ± 6 (c)9 ± 5 (f)Disorganized syndrome9 ± 3 (c)5 ± 2 (f)GAF score46 ± 14 (d)63 ± 19 (f)HDRS-21 score7 ± 9 (g)MADRS score8 ± 12 (h)YMRS score5 ± 9 (e)[^3][^4]

3.1. SBM differences between patients with schizophrenia and healthy controls {#sec0007}
-----------------------------------------------------------------------------

There were significant differences in CV, CT, SA and GI between both groups, which always involved reductions in the patient group (see [Fig. 1](#fig0001){ref-type="fig"} and [Table 2](#tbl0002){ref-type="table"}). Patients with schizophrenia showed a widespread and bilateral pattern of reduction in CV ([Fig. 1](#fig0001){ref-type="fig"}a) including medial and orbitofrontal regions, both insula and surrounding cortex, the temporal cortices and the posterior cingulate, among other regions (see [Table 2](#tbl0002){ref-type="table"} for a complete list of affected regions). CT reductions followed a broadly similar pattern to that observed in CV ([Fig. 1](#fig0001){ref-type="fig"}b) but less extended in fronto medial regions and affecting larger areas of the temporal, parietal and occipital lobes, with enlarged abnormality in ventrolateral prefrontal and premotor cortices (see list on [Table 2](#tbl0002){ref-type="table"}). In contrast, patient related reductions in SA were much less abundant involving only the right superior frontal cortex and a small area of the left lateral occipital cortex (see [Fig. 1](#fig0001){ref-type="fig"}c). Finally, the GI had a differential pattern of bilateral abnormalities including reductions in temporal poles, superior temporal gyrus, insula, parietal areas (mainly supramarginal and postcentral gyri) and frontal caudal regions (see [Fig. 1](#fig0001){ref-type="fig"}d and [Table 2](#tbl0002){ref-type="table"}).Fig. 1Brain regions showing significant statistical differences between patients with schizophrenia and healthy subjects at *p* = 0.05, corrected for multiple comparisons across space. Panels depict cortical volume (a), cortical thickness (b), cortical surface area (c), and gyrification index (d), respectively. The right side of the image represents the left side of the brain. The statistical maps show uncorrected values (i.e., sig = −log10(p)) masked by the significant clusters. The statistical results were only significant in the direction of reduced values in patients.Fig. 1Table 2Results from the SBM differences between patients with schizophrenia and healthy controls analyses. Report of significant regions where patients showed reduced cortical volume, thickness, surface area and gyrification index compared to healthy controls, at *p* \< 0.05, cluster-based corrected for multiple comparisons. Structures are labeled using the Deskian-Killiany atlas included in FreeSurfer and they are ordered by overlapping percentage. The overlapping percentage of each brain region is calculated as 100% x NumVcluster/NumVregion, where NumVcluster is the number of vertices of the cluster within a region and NumVregion is the total number of vertices of that region.Table 2**MetricsMain peakClusterMNI Coordinates (*x,y,z*)*p*-valueNumber of verticesCluster *p*-valueMain involved structures** (ordered by overlapping percentage)**Cortical volume***[Right Brain]{.ul}*Superior frontal cortex(7, 54, 31)\<1e−8855752e−4Insula(100), Isthmus Cingulate (100), Posterior Cingulate (100), Parsorbitalis (100), Transverse Temporal(100), Temporal Pole (100), Frontal Pole(100), Entorhinal (100), Parsopercularis (99),Fusiform (98), Superior Frontal(92), Superior Temporal (86), Paracentral (81)*[Left Brain]{.ul}*Middle temporal cortex(−54, −14, −20)\<1e−8929762e−4Lateral Orbitofrontal (100), Isthmus Cingulate (100), Parsorbitalis (100), Parstriangularis (100),Transverse Temporal (100), Frontal Pole (100), Insula (96), Superior Frontal (95), Middle Temporal (91), Superior Temporal (89), Lateral Occipital (84), Bankssts (84), Posterior Cingulate (83)**Cortical Thickness***[Right Brain]{.ul}*Insula(36, −8, 7)\<1e−91100372e−4Insula (100), Isthmus Cingulate (100), Posterior Cingulate (100), Supramarginal (100), Parsopercularis (100), Parstriangularis (100), Superior Temporal (100), Parahippocampal (100), Middle Temporal (100), Transverse Temporal (100), Temporal Pole (100), Entorhinal (100), Bankssts (100)*[Left Brain]{.ul}*Insula(−35, −6, 11)1e−101099362e−4Superior Temporal (100), Fusiform (100), Middle Temporal (100), Temporal Pole (100), Transverse Temporal (100), Bankssts (100), Entorhinal (100), Inferior Temporal (100), Insula (99), Lingual (95), Parsopercularis (93), Parsorbitalis (91), Parstriangularis (91)**Cortical Surface Area***[Right Brain]{.ul}*Superior frontal cortex(8, 55, 31)\<1e−321493e−3Superior Frontal (18), Frontal Pole (5)*[Left Brain]{.ul}*Lateral occipital cortex(−30, −90, −15)\<1e−31970\<8e−4Lateral occipital (31)**Gyrification index***[Right Brain]{.ul}*Supramarginal(56, −21, 31)\<1e−6559512e−4Postcentral (100), Transverse Temporal (100), Precentral (98), Temporal Pole (98), Supramarginal (94), Caudal Middle Frontal (91), Superior Temporal (78), Parsopercularis (57), Superior Frontal, (48), Insula (46), Rostral Middle Frontal (37)*[Left Brain]{.ul}*Caudal middle frontal cortex(−35, 11, 54)\<1e−7576802e−4Superior Temporal (100), Caudal Middle Frontal (100), Parsopercularis (100), Insula (100), Transverse Temporal (100), Supramarginal (99), Temporal Pole (91), Precentral (72), Postcentral (72), Bankssts (53)Precuneus(−19, −59,15)1e−423110.017Pericalcarine(27),Precuneus (17), Lingual (11)

3.2. SBM differences between patients with bipolar disorder and healthy controls {#sec0008}
--------------------------------------------------------------------------------

As shown in [Fig. 2](#fig0002){ref-type="fig"} there were significant differences in CV and CT between patients with bipolar disorder and healthy controls. As in the previous analyses between schizophrenia patients and controls, these only involved reductions in patients and were frequently placed in the same areas. However, such reductions were clearly less marked in extension than those observed in patients with schizophrenia. Specifically, alteration of CV occurred in moderately sized clusters located in the right frontal cortex (in superior and orbitofrontal areas), temporal lobes and bilateral parietal cortex (supramarginal gyrus and adjacent areas) (see full description in [Table 3](#tbl0003){ref-type="table"}). Cortical thinning abnormalities were slightly more prominent than those in CV, including clusters of larger extension ([Fig. 2](#fig0002){ref-type="fig"}b). Both left and right hemispheres had frontal reductions in CT, mainly including parts of the medial and lateral prefrontal cortices, temporal lobes, insulae and supramarignal gyri, while the occipital cortex was only affected in two sites of the right hemisphere (see [Table 3](#tbl0003){ref-type="table"}). Finally, in contrast to CV and CT results, patients with bipolar disorder did not show any significant area of SA or GI abnormalities when compared to healthy subjects.Fig. 2Brain regions showing significant statistical differences between patients with bipolar disorder and healthy subjects at *p* = 0.05, corrected for multiple comparisons across space. Left and right panels depict cortical volume (a) and cortical thickness (b), respectively. The right side of the image represents the left side of the brain. The statistical maps show uncorrected values (i.e., sig = −log10(p)) masked by the significant clusters. The statistical results were only significant in the direction of reduced values in patients.Fig. 2Table 3Results from the SBM differences between patients with bipolar disorder and healthy controls analyses. Report of significant regions where patients showed reduced cortical volume and thickness compared to healthy controls, at *p* \< 0.05, cluster-based corrected for multiple comparisons. Structures are labeled using the Deskian-Killiany atlas included in FreeSurfer and they are ordered by overlapping percentage. The overlapping percentage of each brain region is calculated as 100% x NumV~cluster~/NumV~region~, where NumV~cluster~ is the number of vertices of the cluster within a region and NumV~region~ is the total number of vertices of that region.Table 3**MetricsMain peakClusterMNI Coordinates (*x,y,z*)*p*-valueNumber of verticesCluster *p*-valueMain involved structures** (ordered by overlapping percentage)**Cortical volume***[Right Brain]{.ul}*Inferior parietal cortex(36, −46, 36)\<1e−839948e−4Inferior parietal (29), Superior parietal (9), Supramarginal (3)Middle temporal cortex(48, −27, −11)\<1e−441276e−4Transverse temporal (90), Superior temporal (26), Middle temporal (22), Insula (10)Superior frontal cortex(9, 56, 30)\<1e−312440.04Superior frontal (10)Lateral orbitofrontal cortex(17, 41, −18)\<1e−332198e−4Lateral orbitofrontal (64), Medial orbitofrontal (9), Frontal pole (5)*[Left Brain]{.ul}*Supramarginal gyrus(−55, −30,35)\<1e−525540.01Supramarginal (24), Postcentral (5)Middle temporal cortex(−64, −26, −16)\<1e−433814e−4Middle temporal (55), Bankssts (14), Superior temporal (6), Inferior temporal (5)Inferior parietal cortex(−32, −58, 37)\<1e−425760.013Inferior parietal (17), Superior parietal (9), Supramarginal (3)**Cortical Thickness***[Right Brain]{.ul}*Transverse temporal cortex(41, −26, 3)\<1e−4162572e−4Transverse temporal (100), Frontal pole (75), Superior temporal (63), Parsorbitalis 63), Insula (60), Parstriangularis (51)Inferior parietal cortex(48, −47, 38)\<1e−471932e−4Supramarginal (39), Inferior parietal (32), Bankssts (26)Lateral occipital cortex(42, −77, −5)\<1e−314260.02Lateral occipital (22), Inferior temporal (3)Caudal middle frontal cortex(30, 14, 47)\<1e−324785e−3Caudal middle frontal (43), Superior frontal (5)Lingual gyrus(14, −61, 2)\<1e−316390.036Lingual (32), Pericalcarine (11), Parahippocampal (7)*[Left Brain]{.ul}*Parsopercularis(−42, 10, 8)\<1e−5218762e−4Transverse temporal (100), Parsopercularis (88), Parsorbitalis (65), Parstriangularis (63), Superior temporal (54), Middle temporal (49), Frontal pole (45), Bankssts (38), Insula (37)Fusiform gyrus(−32, −45, −20)\<1e−317240.02Fusiform (35)Supramarginal gyrus(−40, −51, 35)\<1e−333505e−3Inferior parietal (13), Superior parietal (12), Supramarginal (12)

3.3. SBM differences between patients with schizophrenia and bipolar disorder {#sec0009}
-----------------------------------------------------------------------------

The comparison between the two groups of patients revealed that patients with schizophrenia were significantly more affected in all cortical measures (i.e. all significant results in CV, CT, SA or GI involved reductions in schizophrenia) (see [Fig. 3](#fig0003){ref-type="fig"}). Specifically, there were seven clusters with significant CV differences that were primarily located in a bilateral fashion in the dorsomedial prefrontal and anterior cingulate cortex, in caudal occipital areas, both lateral sulci, right ventral posterior cingulate and right temporal pole (see [Table 4](#tbl0004){ref-type="table"}). All clusters were placed within areas that had shown CV reductions in the healthy control vs. schizophrenia comparison (see both [Figs. 1](#fig0001){ref-type="fig"}a and [3](#fig0003){ref-type="fig"}a). Similarly, albeit less abundantly, differences in CT between both disorders were also located in areas of previous schizophrenia vs. healthy subject reductions ([Fig. 3](#fig0003){ref-type="fig"}b). These mainly included abnormalities in the right dorsal cingulate, left lateral sulcus and left inferior temporal gyrus, posteriorly (see [Table 4](#tbl0004){ref-type="table"}).Fig. 3Brain regions showing significant statistical differences between patients with schizophrenia and patients with bipolar disorder at *p* = 0.05, corrected for multiple comparisons across space. Panels depict cortical volume (a), cortical thickness (b), cortical surface area (c), and gyrification index (d), respectively. The right side of the image represents the left side of the brain. The statistical maps show uncorrected values (i.e., sig = −log10(p)) masked by the significant clusters. The statistical results were only significant in the direction of reduced values in patients with schizophrenia.Fig. 3Table 4Results from the SBM differences between patients with schizophrenia and bipolar disorder analyses. Report of significant regions where patients showed reduced cortical volume, thickness, surface area and gyrification index compared to healthy controls, at *p* \< 0.05, cluster-based corrected for multiple comparisons. Structures are labeled using the Deskian-Killiany atlas included in FreeSurfer and they are ordered by overlapping percentage. The overlapping percentage of each brain region is calculated as 100% x NumV~cluster~/NumV~region~, where NumV~cluster~ is the number of vertices of the cluster within a region and NumV~region~ is the total number of vertices of that region.Table 4**MetricsMain peakClusterMNI Coordinates (*x,y,z*)*p*-valueNumber of verticesCluster *p*-valueMain involved structures** (ordered by overlapping percentage)**Cortical volume***[Right Brain]{.ul}*Insula(36, 7, −11)\<1e−559312e−4Insula (75), Parsopercularis (26), Temporal pole (15)Lingual gyrus(26, −57, 7)\<1e−538398e−4Isthmus cingulate (50), Lingual (24), Precuneus (18), Pericalcarine (14)Superior frontal cortex(78, 34, 45)\<1e−436322e−4Superior frontal (31)Lateral occipital cortex(17, −94, 15)\<1e−430722e−4Lateral occipital (44), Cuneus (5)*[Left Brain]{.ul}*Insula(−36, −1, −6)43988e−4Insula (65), Parsopercularis (22), Parstriangularis (4)Superior frontal cortex(−15, 42, 14)20410.0054Rostral anterior cingulate(24), Superior frontal (14)Lateral occipital cortex(−25, −94, −16)31862e−4Lateral occipital (50)**Cortical Thickness***[Right Brain]{.ul}*Posterior cingulate cortex(4, −4, 30)\<1e−429220.015Posterior cingulate (55), Caudal anterior cingulate (54)*[Left Brain]{.ul}*Insula(−36, −9, −2)1e−539000.00240Insula (51), Superior temporal (17)Fusiform gyrus(−41, −46, −15)\<1e−326160.0028Inferior temporal (30), Fusiform (24), Lateral occipital (2)**Cortical Surface Area***[Right Brain]{.ul}*Lingual gyrus(24, −55, 7)\<1e−321830.026Isthmus cingulate (37), Lingual (21), Precuneus (6)Lateral occipital cortex(18, −94, 16)\<1e−31862\<5e−3Lateral occipital (27), Cuneus (8)*[Left Brain]{.ul}*Lateral occipital cortex(−28, −95, −14)\<1e−31592\< 5e−3Lateral occipital (25)**Gyrification index***[Right Brain]{.ul}*Cuneus(9, −70, 19)1e−334078e−4Cuneus (67), Pericalcarine (53), Precuneus (15), Lingual (4)*[Left Brain]{.ul}*Supramarginal gyrus(−56, −37, 32)\<1e−490492e−4Supramarginal (68), Postcentral (26), Superior temporal (6)Cuneus(−13, −69, 15)\<1e−395872e−4Pericalcarine (79), Precuneus (67), Cuneus (64), Lingual (45), Isthmus cingulate (11)

In contrast, SA results not always had such anatomical matching with areas of SA reduction found in the schizophrenia vs. healthy control comparison. However, all reported differences in SA between both disorders included areas that had shown CV differences in the same cross-disorder comparison (see [Fig. 3](#fig0003){ref-type="fig"}a and c). These comprised both posterior occipital regions and the right ventral posterior cingulate (see [Table 4](#tbl0004){ref-type="table"}). Finally, inter-disorder differences in GI included a cluster in the left supramarginal gyrus (which had previously shown extensive reductions in the schizophrenia vs. control comparison) but also included bilateral abnormalities in the cuneus that spread over the left precuneus and left primary visual areas and which, apart from a small fraction of the left side cluster, were not present at all in the schizophrenia vs. control comparison (see [Figs. 1](#fig0001){ref-type="fig"}d and [3](#fig0003){ref-type="fig"}d).

4. Discussion {#sec0010}
=============

We found that patients with schizophrenia showed widespread CV and CT reductions compared to healthy subjects. CV reductions in medial brain structures, frontotemporal regions including the insula, and lateral occipital cortex are partially consistent with previous meta-analyses of VBM studies ([@bib0004]; [@bib0023]). Similarly, CT reductions have also been reported in schizophrenia in several studies ([@bib0052]; [@bib0059]; [@bib0018]).

In our study, SA reductions in patients with schizophrenia were also found, indicating that although the reduction in CV is largely explained by cortical thinning, it is also affected by SA changes. It is worth mentioning that a previous study by our group ([@bib0031]) found that schizoaffective patients showed widespread CV reduction and a region of decreased SA in the left fusiform gyrus. Interestingly, this area is close to the left lateral occipital cortex, where we have reported SA reduction in patients with schizophrenia. Additionally, our results are partially consistent with a recent ENIGMA meta-analysis, which found that patients with schizophrenia had widespread thinner cortex, with the largest effect sizes in frontal and temporal lobe regions ([@bib0060]). However, opposite to our focal SA reduction findings, they found smaller but widespread SA reduction, which may be explained by a higher sensitivity to detect small changes due to larger sample size ([@bib0060]). Another finding of this study is reduced GI in patients with schizophrenia compared to healthy subjects. Abnormalities were found in frontal, temporal and parietal regions. Decreased GI in the left insula, superior/middle/inferior frontal cortex, supramarginal cortex and Broca\'s area has been also reported in previous studies ([@bib0042]; [@bib0044]; [@bib0058]). Also in agreement with our results, another study based on two large independent samples of Swedish and Norwegian patients with schizophrenia showed reduced GI in the left pericentral region, comparared to healthy subjects ([@bib0041]).

Patients with bipolar disorder showed reduced CV in right frontal, temporal and parietal regions compared to healthy subjects. Interestingly, abnormalities in the grey matter of the right prefrontal cortex and temporal lobe were described as the most robust in a meta-analysis of VBM studies in bipolar disorder ([@bib0056]). Cortical thinning in bipolar disorder were found in similar but more extensive areas than CV. Similar areas with reduced CT have already been reported by other authors, including the left superior and middle temporal cortex ([@bib0012]; [@bib0035]), superior frontal cortex ([@bib0012]; [@bib0015]; [@bib0035]), orbitofrontal cortex ([@bib0015]; [@bib0033])*,* and right parahippocampal gyrus ([@bib0024]). More recently, the largest ENIGMA meta-analysis of CT and SA in bipolar disorder found evidence of widespread bilateral cortical thinning in frontal, temporal and parietal regions ([@bib0022]). Longer duration of illness and medication were associated with reduced CT in these regions. Interestingly, there is a substantial overlap between some of the reported regions with the strongest effect sizes (i.e., left frontal operculum and left fusiform gyrus) and our results. In addition, opposite to our negative results in relation to SA abnormalities in bipolar patients, they found localized SA reduction in the insula. Although, it was only found in a subgroup of young adults and it was associated with a history of psychosis and medication ([@bib0022]). Furthermore, no region of significant gyrification abnormalities between patients with bipolar disorder and healthy subjects were found in our study. Hence, our results point towards a reduction in the cortical volume of patients with bipolar disorder, which is exclusively explained by cortical thinning but not by changes in the surface area or gyrification pattern. Finally, it is important to mention that patients with bipolar disorder showed significant thinning of the right caudal middle frontal cortex (DLPFC). Reduced functional activation of this area has been reported in a number of functional MRI studies, e.g. ([@bib0047]).

One of the main novelties of the present study concerns the direct comparison between patients with schizophrenia and bipolar disorder. This analysis is important to evaluate to what extent the underlying cortical morphological alterations differ between these two disorders. To date, the limited number of studies that have compared both disorders usually found more grey matter deficits in schizophrenia. However, the cortical regions implicated by these deficits were rather heterogeneous across studies ([@bib0002]; [@bib0005]; [@bib0025]; [@bib0057]). In agreement with these studies, we found that CV reductions are more pronounced in patients with schizophrenia. Our results point to significant abnormalities affecting frontal, temporal and occipital regions. Recently, the European Network on Psychosis, Affective disorders, and Cognitive Trajectory analyzed a big sample of patients with schizophrenia and bipolar disorder combining ROI and VBM analyses. In line with our results, both disorders exhibited shared fronto-temporo-occipital grey matter deficits, and schizophrenia was associated with more severe abnormalities in a number of regions including the insula ([@bib0034]). In addition to widespread CV reduction, in our study patients with schizophrenia showed reduced CT in relation to patients with bipolar disorder in the right anterior/posterior cingulate cortex and left temporal regions, including the insula. Only a few studies have directly compared cortical thickness between patients with schizophrenia and bipolar disorder. A recent review identified a similar pattern of cortical thinning in both disorders in frontal and temporal regions, including the parahippocampal and fusiform gyrus, suggesting some common neuropathology ([@bib0021]). Likewise, a similar bilateral cortical thinning in both groups, mainly affecting the operculum and the anterior/posterior cingulate cortex was reported in [@bib0030]). Similar to us, these studies found a more pronounced cortical thinning in schizophrenia than in bipolar disorder, involving similar but also different regions. In this sense, our study adds more evidence to the hypothesis that thinning of the frontal cortex may represent a biological feature shared by both disorders. As was found by [@bib0024]), common areas of thinner cortex could be associated with higher genetic liabilities for both disorders.

In terms of SA, patients with schizophrenia showed smaller SA than patients with bipolar disorder in posterior brain regions, including the lingual gyrus, precuneus, cuneus and occipital cortex. It is worth noting that only one previous study attempted to compare abnormalities in CV, CT, and SA among schizophrenia, bipolar disorder, and healthy controls ([@bib0052]). Our study adds two novelties to this previous study. First, in addition to these cortical metrics, we also compared the gyrification patterns. Second, we took into account the total brain volume as a confounding factor in the analyses. Our findings are partially in line with this previous study. One the one hand, in both studies patients with schizophrenia showed CV, CT and SA reductions compared with healthy subjects. Moreover, SA reductions were detected in patients with schizophrenia, but not in bipolar patients. On the other hand, however, while the SA reductions found by [@bib0052]) in schizophrenia were widespread, only focal SA changes were identified in our study. The biggest discrepancy between both studies is that we found CV reductions in bipolar patients, while [@bib0052]) did not. Despite CT reductions were found in patients with bipolar disorder in both studies, in [@bib0052]) a non-significant SA increase was detected in patients which counteracted the cortical thinning. This discrepancy may be explained by differences in the statistical models used in both studies. In our study, the intra-cranial volume was included as a covariate because it is highly correlated with SA, and thus with CV ([@bib0064]). If this factor is not taken into account, local morphological differences may be confounded with differences in total brain volume. The comparison between patients groups carried out in [@bib0052]) found that practically all differences in CV were driven by changes in SA, while in our in study significant changes in both SA and CT were found.

In line with previous studies, suggesting that CT may be more influenced by additional environmental and neurodegenerative factors ([@bib0003]), while cortical SA developmental trajectories in psychosis may be predominantly influenced by early neurodevelopmental and genetic factors ([@bib0045]; [@bib0064]; [@bib0026]), our results support the hypothesis for a strongest neurodevelopmental disturbance in schizophrenia than in bipolar disorder, as SA reductions were only found in patients with schizophrenia.

Another main contribution of this study was the gyrification abnormalities found in patients with schizophrenia compared to bipolar disorder. In particular, we found a decreased GI in patients with schizophrenia in the left parietal and temporal cortex, as well as in both sides of the dorsal medial part of the occipital cortex. To date, only a few studies have directly compared GI between both disorders, but including small sample of patients. For instance, a previous study found that patients with schizophrenia and bipolar disorder have a similar pattern of reduced prefrontal gyrification, which was associated with cognitive impairments ([@bib0037]). Another study reported an overlapping reduction in gyrification (i.e., 25%) in the lateral prefrontal cortex in both patient groups ([@bib0043]). Finally, decreased GI has been observed in adolescents with psychotic bipolar disorder and schizophrenia, suggesting it may represent a shared endophenotype for psychosis ([@bib0027]).

This study has some limitations. In common with other neuroimaging studies of psychosis, patients were medicated. Furthermore, our samples were made up of right-handed subjects, which may induce a sampling bias. It is important to note that left-handedness has been found to be over-represented in schizophrenia. Moreover, our samples were recruited to be matched by age, gender and premorbid IQ and this may cause selection bias. For example, the proportion of men with schizophrenia was higher than that of women (74/54) and it caused a selection bias of the bipolar patients and healthy subjects. On the other hand, a limitation related to matching by age is that this may cause a selection bias in terms of years of evolution. Unfortunately, it is not possible to match these two variables at the same time, so we preferred to recruit age-matched participants. Finally, it is important to note that we matched by premorbid IQ and patients were also required to have a current IQ in the normal range (i.e.\>70). We hope that this procedure contributed to reducing any IQ-related sampling bias. Finally, subjects with alcohol or drug abuse were excluded. Data on substance abuse in the past were not systematically collected and might have differed between the three groups. Therefore, our results should not be generalized to the whole population of patients and healthy controls but to subpopulations satisfying these clinical and demographic characteristics. Future studies should investigate the value of cortical morphology for distinguishing major psychiatric disorders, for instance, by using machine learning algorithms as a diagnostic prediction tool in psychosis ([@bib0054]). Moreover, new studies should be conducted to investigate the alterations in white matter tissue using multiple features derived from diffusion MRI data ([@bib0006]) allowing the individual characterization of microstructural parameters ([@bib0010]) and their relation to white matter genes ([@bib0017]). Multi-modal studies ([@bib0048]) may help to provide a better understanding of the underlying neurobiology of schizophrenia and bipolar disorder, as well as a more robust biomedical background to the aetiology of either condition, which might ultimately lead to improvements in diagnosis and treatment.

5. Conclusions {#sec0011}
==============

Cortical volume and cortical thickness deficits are shared between patients with schizophrenia and bipolar disorder, suggesting that both pathologies may be affected by similar environmental and neurodegenerative factors. However, in bipolar disorder, these abnormalities are less pronounced. These results are in line with previous studies using different imaging techniques, as well as with genetics and neuropsychological studies, which point towards a shared neurobiological underpinning between both disorders. However, in schizophrenia, these abnormalities are more pronounced and may be related to psychotic symptoms. The exclusive alteration in schizophrenia of metrics related to the local geometry and curvature of the brain cortical surface suggests that this group is influenced by additional neurodevelopmental and genetic factors. Taken together, these data point towards a shared neurobiological underpinning between both pathologies, but with additional components affecting schizophrenia.
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